South China Morning Post CENTER (0.0) Reliability: 7.5/10

CK Life unit merges with TransCode as Li Ka-shing firm eyes anticancer drugs pipeline

✍️ Cheryl Arcibal 📅 October 09, 2025 09:45 AM 🕐 Scraped: October 09, 2025

Summary: Upon completion of the transaction, CK Life will own about 9.1 per cent of TransCode’s outstanding common shares.

CK Life Sciences International is set to merge its subsidiary Polynoma with Nasdaq-listed TransCode Therapeutics, in a move expected to boost the pipeline of anticancer drugs, according to the biot

📰

Continue Reading on South China Morning Post

This preview shows approximately 15% of the article. Read the full story on the publisher's website to support quality journalism.

Read Full Article →

How do you feel about this article?

Read Original Article →

📝 Article Information

Author

Cheryl Arcibal

Original Publisher

🌍 South China Morning Post

CENTER Bias (0.0)

Published Date

October 09, 2025 at 09:45 AM

ℹ️

Disclaimer

ArkforgeAI.com - Newsource is a news aggregation platform. We do not create, write, or produce original news content. All articles are sourced from their respective publishers and remain the property of their original creators. We analyze and aggregate news from multiple sources to provide diverse perspectives across the political spectrum.

The content displayed here is for informational purposes only. For the complete and original article, please visit the source's website using the "Read Original Article" link above.

Desktop Only